Extendicare Inc. Showcases Strong Growth in Earnings Call

Extendicare Inc. ((TSE:EXE)) has held its Q4 earnings call. Read on for the main highlights of the call.

Extendicare Inc. used its latest earnings call to underline strong momentum across its core operations, with management striking an upbeat yet measured tone. Executives highlighted double‑digit growth in home health, expanding margins, and successful acquisitions as the main drivers, while framing integration work, rural labor tightness, and higher leverage as manageable trade‑offs for faster growth.

Strong Adjusted EBITDA Growth

Extendicare reported adjusted EBITDA of $45.6 million in Q4, up 36.4% year over year after stripping out out‑of‑period items. Consolidated net operating income climbed 30.2%, or $14.3 million, underscoring significant operating leverage as revenues and margins expanded across the portfolio.

Robust Home Health Expansion

Home health arm ParaMed remained the growth engine, delivering 15.3% organic volume growth in Q4. Segment revenue jumped 33.6%, or $49.7 million, helped by the Closing the Gap deal, while home health NOI margins widened 280 basis points to 13.2% excluding one‑offs.

Long-Term Care Margin Improvement and Occupancy

In long‑term care, NOI margins improved 90 basis points to 10.9% in Q4 on an ex‑items basis. Occupancy held near full capacity at 98%, reinforcing the stability of this regulated, government‑funded revenue stream even as the company redevelops and modernizes its bed base.

Acquisitions Running Ahead of Plan

Management said the integration of the Revera long‑term care homes is now complete, while Closing the Gap is tracking ahead of pro forma expectations. Together, these acquisitions added about $61.8 million of revenue in Q4, validating the strategy of using M&A to scale in both care settings.

Strategic CBI Home Health Deal

Extendicare’s planned $570 million acquisition of CBI Home Health is set to be a transformational step in home care. The deal is expected to add roughly 10 million hours of service, $478 million of revenue and $61.9 million in pro forma adjusted EBITDA, and to be 9% EPS accretive at closing, rising to 15% once synergies are captured.

Liquidity and Financing Strengthened

To support its growth pipeline, the company raised $200 million in a bought deal, generating $191.5 million of net proceeds. It also expanded senior secured credit facilities by $214.5 million, finishing the year with $348 million in cash and $154 million of available credit, positioning leverage near 2.7–2.9 times adjusted EBITDA post‑CBI.

Dividend Increase Signals Confidence

Extendicare announced a 5% boost to its monthly dividend to $0.0441, marking a second straight year of increases. The payout ratio stood at 42% for Q4 and 46% for the full year on an adjusted basis, suggesting management sees room to reward shareholders while funding expansion.

Redevelopment and Asset Recycling

The company pushed ahead with its redevelopment pipeline, including early construction on a new 320‑bed Sudbury home and seven homes under construction totaling $692.3 million of investment. It also monetized the vacated West End Villa for $12.5 million, booking a $10.1 million after‑tax gain to recycle capital into higher‑return projects.

Managed Services Scale and Profitability

Extendicare’s SGP managed services platform grew to over 153,500 third‑party and joint‑venture beds, up 5% year over year. Despite some contract losses, the business maintained robust NOI margins of 55.5%, comfortably within the long‑term 50–55% target range.

Underlying AFFO Improvement

Excluding out‑of‑period items, adjusted funds from operations per basic share rose 6% to $0.301, pointing to healthier underlying cash generation. This improvement came even as the company absorbed integration costs and stepped up investment in newly acquired facilities.

Reported AFFO and Maintenance CapEx

Reported Q4 AFFO per share was $0.337, slightly lower than last year, as the timing of higher maintenance capital expenditures weighed on results. Additional upkeep for acquired long‑term care homes temporarily dampened reported earnings despite the underlying AFFO growth on an ex‑items basis.

Equity Issuance Dilution

A December 2025 equity financing modestly diluted per‑share results, shaving about $0.01 from AFFO and EPS in Q4. Management framed the issuance as a necessary step to fund growth and keep leverage at manageable levels while pursuing the CBI transaction.

Managed Services Revenue Headwinds

Managed services revenue fell by $3.6 million to $15.3 million, with NOI down $1.8 million to $8.5 million in the quarter. The decline was driven by the termination of management contracts after a portfolio sale by Revera, highlighting some lumpiness in this high‑margin stream.

Revenue Impact from Class C Closures

The closure of certain redeveloped Class C long‑term care homes led to an estimated $7.6 million revenue shortfall in Q4 and a roughly $0.5 million NOI hit. These near‑term losses partially offset gains from acquisitions but are part of a broader upgrade strategy expected to improve economics over time.

Out-of-Period Items Add Volatility

Quarterly results were influenced by about $3.9 million of net favorable out‑of‑period items, including workers’ compensation rebates and retroactive wage adjustments. Long‑term care also recorded $1.6 million of out‑of‑period costs versus $1.9 million of funding last year, creating noisy year‑over‑year comparisons.

Rural Labor Constraints

Management noted that recruitment remains challenging in some rural and remote regions, limiting the ability to take all home‑care referrals in those markets. However, they emphasized that hiring in major urban centers is adequate, helping sustain strong growth in overall home health volumes.

Integration Focus and M&A Pause

The sizeable CBI deal still depends on regulatory approvals, injecting some timing risk into the outlook. Once complete, the company expects to pause major M&A in 2026 to focus on integrating Closing the Gap and CBI, temporarily shifting emphasis from external deals to internal execution.

Higher Leverage to Fund Growth

Funding the CBI acquisition will lift pro forma leverage to about 2.7–2.9 times total debt to adjusted EBITDA. While this remains within typical comfort zones for the sector, it raises execution risk if synergies are slower to materialize or operating trends soften.

Forward-Looking Guidance and Outlook

Management is targeting an early‑Q2 close for the CBI acquisition and expects Closing the Gap integration to be finished by Q3, with pro forma leverage around 2.7–2.9 times. They foresee continued strong home‑health growth, margins around or above 13%, managed services margins holding near 50–55%, solid long‑term care occupancy and margins, and cash tax in 2026 at roughly 24–27% of pretax FFO.

Extendicare’s earnings call painted a picture of a company leaning into scale and efficiency to capture rising demand for seniors’ care. Investors will be watching integration milestones, leverage and labor trends, but for now the balance of accelerating growth, improving margins and a growing dividend leaves the story tilted firmly to the upside.